$1.35
0.0082[0.61%]
Last update: 9:28AM Get Real Time Here
Artelo Biosciences
(NASDAQ:ARTL)Artelo Biosciences Stock (NASDAQ:ARTL), Analyst Ratings, Price Targets, Predictions
Artelo Biosciences Inc has a consensus price target of $32.5, established from looking at the 6 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and Ladenburg Thalmann on April 2, 2024, November 14, 2023, and April 3, 2023. With an average price target of $23.33 between HC Wainwright & Co., HC Wainwright & Co., and Ladenburg Thalmann, there's an implied 1628.40% upside for Artelo Biosciences Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
Ladenburg Thalmann
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Artelo Biosciences
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/02/2024 | ARTL | Buy Now | Artelo Biosciences | $1.35 | 270.37% | HC Wainwright & Co. | Vernon Bernardino | $5 → $5 | Maintains | Buy | Get Alert |
| 11/14/2023 | ARTL | Buy Now | Artelo Biosciences | $1.35 | 270.37% | HC Wainwright & Co. | Vernon Bernardino | → $5 | Reiterates | Buy → Buy | Get Alert |
| 04/03/2023 | ARTL | Buy Now | Artelo Biosciences | $1.35 | 4344.44% | Ladenburg Thalmann | Michael Higgins | → $60 | Reiterates | → Buy | Get Alert |
| 02/03/2023 | ARTL | Buy Now | Artelo Biosciences | $1.35 | 3974.07% | HC Wainwright & Co. | Vernon Bernardino | → $55 | Reiterates | → Buy | Get Alert |
| 08/12/2022 | ARTL | Buy Now | Artelo Biosciences | $1.35 | 3974.07% | HC Wainwright & Co. | Vernon Bernardino | → $55 | Maintains | Buy | Get Alert |
| 11/01/2021 | ARTL | Buy Now | Artelo Biosciences | $1.35 | 196.3% | HC Wainwright & Co. | Vernon Bernardino | — | Initiates | → Buy | Get Alert |
FAQ
What is the target price for Artelo Biosciences (ARTL)?
The latest price target for Artelo Biosciences (NASDAQ: ARTL) was reported by HC Wainwright & Co. on April 2, 2024. The analyst firm set a price target for $5.00 expecting ARTL to rise to within 12 months (a possible 270.37% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Artelo Biosciences (ARTL)?
The latest analyst rating for Artelo Biosciences (NASDAQ: ARTL) was provided by HC Wainwright & Co., and Artelo Biosciences maintained their buy rating.
When was the last upgrade for Artelo Biosciences (ARTL)?
There is no last upgrade for Artelo Biosciences.
When was the last downgrade for Artelo Biosciences (ARTL)?
There is no last downgrade for Artelo Biosciences.
When is the next analyst rating going to be posted or updated for Artelo Biosciences (ARTL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Artelo Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Artelo Biosciences was filed on April 2, 2024 so you should expect the next rating to be made available sometime around April 2, 2025.
Is the Analyst Rating Artelo Biosciences (ARTL) correct?
While ratings are subjective and will change, the latest Artelo Biosciences (ARTL) rating was a maintained with a price target of $5.00 to $5.00. The current price Artelo Biosciences (ARTL) is trading at is $1.35, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.